PVI
AGTC

Pura Vida Investments’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Pura Vida Investments’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-206,423
Closed -$1.05M – 297
2021
Q1 		$1.05M Buy
+206,423
New +$1.07M 0.03% 188
2020
Q4 		– Sell
-176,411
Closed -$857K – 234
2020
Q3 		$857K Sell
176,411
-15,488
-8% -$84.6K 0.04% 134
2020
Q2 		$1.06M Sell
191,899
-15,459
-7% -$70.8K 0.1% 104
2020
Q1 		$680K Buy
+207,358
New +$1.09M 0.08% 81

Other funds holding AGTC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Pura Vida Investments's AGTC Position: Q2 2021 in Review

Pura Vida Investments sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 206,423 shares — an estimated $1.05M sold.

Pura Vida Investments first reported a position in AGTC in Q1 2020 and held it in 4 quarters. The position peaked at $1.06M in Q2 2020. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

  • Pura Vida Investments reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 206,423 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $1.05M.
  • Pura Vida Investments first reported a position in Applied Genetic Technologies Corporation in Q1 2020 and held it in 4 quarters.
  • Pura Vida Investments's Applied Genetic Technologies Corporation position peaked at $1.06M in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.